Is Virocell Biologics Ltd in administration?
Last verified 5 June 2026
Yes, Virocell Biologics Ltd (company number 13033264) entered administration on 4 December 2025.
Do you deal with companies like Virocell Biologics Ltd? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Virocell Biologics Ltd is now under the control of an administrator. Below are the key dates, the directors, the public-record timeline that led here, and what the administration means if you are a creditor, employee, customer or supplier.
Company at a glance
| Status | In Administration |
|---|
| Company number | 13033264 |
|---|
| Incorporated | 20 November 2020 (6 years old) |
|---|
| Registered office | Frp Advisory Trading Ltd, 110 Cannon Street, London, EC4N 6EU |
|---|
| Nature of business (SIC) | 72110: Research and experimental development on biotechnology |
|---|
| Date entered administration | 4 December 2025 |
|---|
| Official notice | View the official notice ↗ |
|---|
| Statement of Affairs | Filed 9 December 2025, declared assets & liabilities ↗ |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Virocell Biologics Ltd is a UK limited company based in London, incorporated in 2020 and 5 years old when the administrator was appointed. Its registered activity is research and experimental development on biotechnology (SIC 72110). There have been 9 director appointments since incorporation, of which 7 were on the board when the administrator was appointed, alongside 1 person with significant control. 1 charge has been registered against the company, 1 of which is still outstanding.
Directors
9 people have been appointed as directors of Virocell Biologics Ltd.
DirectorStatusAppointedResigned
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Sartorius Stedim Biotech Gmbh
corporate entity person with significant control
Ownership of shares 25-50%Voting rights 25-50%
7 ceased controls
- Edmund George Imjin Fosbroke Truell · ceased 29 Jan 2021
- Todd C Davis · ceased 14 Apr 2021
- Amie B Hadden · ceased 14 Apr 2021
- Long Term Assets Limited · ceased 18 May 2022
- The Truell Conservation Foundation · ceased 18 May 2022
- Mr Todd Davis · ceased 31 Jul 2023
- The Truell Conservation Foundation · ceased 31 Jul 2023
Charges register
Secured creditors and encumbrances against the company. 1 outstanding · 0 satisfied.
Status · Creditor · Type · Dates
OutstandingNicholas Denzil Stephens for and on Behalf of the Secured Parties
A registered charge · Created 29 Sep 2025 · Pending
What happened
EventDateType
Administrator's progress report6 July 2026AM10 Notice of deemed approval of proposals9 January 2026AM06
Statement of administrator's proposal10 December 2025AM03 Statement of affairs9 December 2025AM02 Registered office address changed4 December 2025AD01 +118 earlier events · 2021 to 2025
Appointment of an administrator4 December 2025AM01 Registered office address changed4 December 2025AD01 Registration of charge , created30 September 2025MR01 Memorandum and Articles of Association21 August 2025MA Memorandum and Articles of Association28 July 2025MA Director's details changed30 May 2025CH01 Director's details changed29 May 2025CH01 Director's details changed29 May 2025CH01 Director's details changed29 May 2025CH01 Director's details changed29 May 2025CH01 Registered office address changed29 May 2025AD01 Director's details changed29 May 2025CH01 Statement of capital following an allotment of shares6 March 2025SH01 Memorandum and Articles of Association27 February 2025MA Confirmation statement made with updates16 December 2024CS01 Total exemption full accounts made up30 September 2024AA Confirmation statement made with updates20 December 2023CS01 Notification as a person with significant control13 December 2023PSC02 Cessation as a person with significant control13 December 2023PSC07 Cessation as a person with significant control13 December 2023PSC07 Statement of capital following an allotment of shares13 December 2023SH01 Total exemption full accounts made up28 September 2023AA Appointment as a director1 September 2023AP01 Termination of appointment as a director1 September 2023TM01 Director's details changed26 May 2023CH01 Director's details changed26 May 2023CH01 Director's details changed25 May 2023CH01 Director's details changed25 May 2023CH01 Director's details changed25 May 2023CH01 Director's details changed25 May 2023CH01 Registered office address changed25 May 2023AD01 Director's details changed25 May 2023CH01 Appointment as a director15 March 2023AP01 Appointment as a director10 February 2023AP01 Register inspection address has been changed20 January 2023AD02 Register(s) moved to registered inspection location20 January 2023AD03 Statement of capital following an allotment of shares19 January 2023SH01 Memorandum and Articles of Association19 January 2023MA Confirmation statement made with updates20 December 2022CS01 Statement of capital following an allotment of shares9 September 2022SH01 Statement of capital following an allotment of shares9 September 2022SH01 Statement of capital following an allotment of shares9 September 2022SH01 Memorandum and Articles of Association26 August 2022MA Total exemption full accounts made up19 August 2022AA Statement of capital following an allotment of shares17 August 2022SH01 Statement of capital following an allotment of shares17 August 2022SH01 Statement of capital following an allotment of shares17 August 2022SH01 Statement of capital following an allotment of shares17 August 2022SH01 Notification as a person with significant control26 July 2022PSC01 Statement of capital following an allotment of shares26 July 2022SH01 Sub-division of shares25 July 2022SH02 Cessation as a person with significant control25 July 2022PSC07 Notification as a person with significant control25 July 2022PSC02 Statement of capital following an allotment of shares21 July 2022SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares20 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Statement of capital following an allotment of shares19 July 2022SH01 Second filing of a statement of capital following an allotment of shares19 July 2022RP04SH01 Statement of capital following an allotment of shares22 June 2022SH01 Second filing of a statement of capital following an allotment of shares7 June 2022RP04SH01 Statement of capital following an allotment of shares30 May 2022SH01 Statement of capital following an allotment of shares26 May 2022SH01 Cessation as a person with significant control19 May 2022PSC07 Notification as a person with significant control18 May 2022PSC02 Cessation as a person with significant control18 May 2022PSC07 Statement of capital following an allotment of shares4 May 2022SH01 Sub-division of shares22 February 2022SH02 Confirmation statement made with no updates7 December 2021CS01 Appointment as a director29 October 2021AP01 Statement of capital following an allotment of shares21 September 2021SH01 Statement of capital following an allotment of shares13 September 2021SH01 Second filing of a statement of capital following an allotment of shares7 September 2021RP04SH01 Statement of capital following an allotment of shares6 August 2021SH01 Statement of capital following an allotment of shares8 June 2021SH01 Statement of capital following an allotment of shares25 May 2021SH01 Statement of capital following an allotment of shares17 May 2021SH01 Memorandum and Articles of Association6 May 2021MA Cessation as a person with significant control29 April 2021PSC07 Notification as a person with significant control27 April 2021PSC01 Appointment as a director27 April 2021AP01 Notification as a person with significant control27 April 2021PSC01 Statement of capital following an allotment of shares26 April 2021SH01 Appointment as a director23 April 2021AP01 Change of details as a person with significant control23 April 2021PSC05 Current accounting period extended14 April 2021AA01 Registered office address changed24 February 2021AD01 Cessation as a person with significant control17 February 2021PSC07 Appointment as a director29 January 2021AP01 Termination of appointment as a director29 January 2021TM01 Appointment as a director29 January 2021AP01 Incorporation20 November 2020NEWINC What this means for you
If you are a creditor
Contact the administrator to register your claim. You cannot start or continue legal action against the company without the court's or administrator's permission. Unsecured creditors are typically paid last.
A creditor's checklist →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Orders, deposits and warranties may be affected. Deposits paid are usually unsecured claims. Contact the administrator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the appointment are an unsecured claim. Check whether any retention-of-title clause applies to goods you can identify and recover.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other companies in administration
Related guides
The bigger picture
Frequently asked questions
- Is Virocell Biologics Ltd in administration?
- Yes. Virocell Biologics Ltd (company number 13033264) entered administration on 4 December 2025.
- What does Virocell Biologics Ltd do?
- Virocell Biologics Ltd's registered nature of business is research and experimental development on biotechnology (SIC 72110).
- Where is Virocell Biologics Ltd based?
- Virocell Biologics Ltd's registered office is Frp Advisory Trading Ltd, 110 Cannon Street, London, EC4N 6EU. The registered office is the address held on the public register, which is not always the trading address.
- When was Virocell Biologics Ltd founded?
- Virocell Biologics Ltd was incorporated on 20 November 2020, 5 years before the administrator was appointed.
- What is Virocell Biologics Ltd's company number?
- Virocell Biologics Ltd's registered company number is 13033264.
- Who has significant control of Virocell Biologics Ltd?
- 1 active person with significant control over Virocell Biologics Ltd is on the register: Sartorius Stedim Biotech Gmbh.
- Does Virocell Biologics Ltd have any outstanding charges?
- an outstanding charge is registered against Virocell Biologics Ltd out of 1 on file. Outstanding charges represent secured creditors who rank ahead of unsecured creditors in any recovery.
- Are jobs at Virocell Biologics Ltd at risk?
- When a company enters administration the administrator decides whether to continue trading, sell the business as a going concern, or wind it down. Employees can contact the administrator for any update on their role, and may be able to claim from the Redundancy Payments Service if their job is made redundant.
- What does administration mean for creditors of Virocell Biologics Ltd?
- Administration is a formal insolvency process that gives a company protection from creditors while an administrator tries to rescue it or achieve a better result than liquidation. Creditors cannot start or continue legal action without permission. Unsecured creditors are usually paid last, often only a portion of what they are owed, if anything.
- When did Virocell Biologics Ltd go into administration?
- Virocell Biologics Ltd went into administration on 4 December 2025.
Report an error on this page·Not financial, credit or legal advice.